Suvanza is an early-stage biotechnology corporation that focuses on the development of advanced through the skin drug delivery system for Dermatological diseases. Suvanza delivery system is safe, uses less active ingredients, has reduced systemic uptake, and provides the opportunity to use multiple actives, which do not interact prior to application. SUVZ: OTC
| Website | http://www.suvanza.com |
| Revenue | $2 million |
| Employees | 9 (4 on RocketReach) |
| Founded | 1998 |
| Address | 5401 Collins Avenue CU-9A, Miami Beach, Florida 33140, US |
| Phone | +1 866-633-9546 |
| Fax | (305) 867-7807 |
| Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Drug Delivery, Retail |
| Keywords | Biotech Research, Transdermal Drug Delivery, Advanced Drug Delivery, Biotechnology, Pharmaceutical Research, Drug Development, Topical Medications, Microneedle Patches, Drug Delivery Systems, Therapeutic Patches, Transdermal Patches, Pharmaceutical Innovation, New Drug Delivery, Innovative Drug Delivery |
| Competitors | Sirius Technologies Ltd, Antenna Group, Celerity It LLC, Cohesive Solutions, Infor, Xoriant, QASymphony, Magenic Manila, Inc., Softura, Akvelon, Inc. +32 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Suvanza, Inc. employee's phone or email?
The Suvanza, Inc. annual revenue was $2 million in 2026.
4 people are employed at Suvanza, Inc..
Suvanza, Inc. is based in Miami Beach, Florida.
The NAICS codes for Suvanza, Inc. are [3254, 325, 32541, 32].
The SIC codes for Suvanza, Inc. are [283, 28].